3.26
price up icon12.41%   0.36
after-market Handel nachbörslich: 3.25 -0.010 -0.31%
loading
Schlusskurs vom Vortag:
$2.90
Offen:
$2.95
24-Stunden-Volumen:
14.22M
Relative Volume:
4.72
Marktkapitalisierung:
$889.31M
Einnahmen:
$8.10M
Nettoeinkommen (Verlust:
$-92.72M
KGV:
-9.5882
EPS:
-0.34
Netto-Cashflow:
$-82.52M
1W Leistung:
+15.19%
1M Leistung:
+20.30%
6M Leistung:
+100.00%
1J Leistung:
+57.49%
1-Tages-Spanne:
Value
$2.91
$3.28
1-Wochen-Bereich:
Value
$2.785
$3.28
52-Wochen-Spanne:
Value
$1.05
$3.31

Taysha Gene Therapies Inc Stock (TSHA) Company Profile

Name
Firmenname
Taysha Gene Therapies Inc
Name
Telefon
(214) 612-0000
Name
Adresse
3000 PEGASUS PARK DRIVE, DALLAS
Name
Mitarbeiter
73
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
TSHA's Discussions on Twitter

Vergleichen Sie TSHA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TSHA
Taysha Gene Therapies Inc
3.26 774.74M 8.10M -92.72M -82.52M -0.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-11 Eingeleitet BofA Securities Buy
2024-06-27 Eingeleitet BMO Capital Markets Outperform
2024-04-09 Eingeleitet Piper Sandler Overweight
2023-02-01 Herabstufung Jefferies Buy → Hold
2023-01-27 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-11-09 Herabstufung Goldman Buy → Neutral
2022-03-09 Eingeleitet Robert W. Baird Outperform
2022-03-01 Eingeleitet Wells Fargo Overweight
2022-02-18 Eingeleitet SMBC Nikko Outperform
2021-12-16 Eingeleitet Guggenheim Buy
2021-07-16 Eingeleitet Needham Buy
2021-06-24 Eingeleitet Truist Buy
2021-06-15 Eingeleitet BTIG Research Buy
2021-06-09 Eingeleitet Wedbush Outperform
2021-06-08 Eingeleitet JMP Securities Mkt Outperform
2021-05-19 Eingeleitet Cantor Fitzgerald Overweight
2021-05-11 Fortgesetzt Jefferies Buy
2021-02-24 Eingeleitet William Blair Outperform
2021-01-05 Eingeleitet Oppenheimer Outperform
2020-10-19 Eingeleitet Chardan Capital Markets Buy
2020-10-19 Eingeleitet Goldman Buy
2020-10-19 Eingeleitet Jefferies Buy
2020-10-19 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Taysha Gene Therapies Inc Aktie (TSHA) Neueste Nachrichten

pulisher
Sep 03, 2025

Will Taysha Gene Therapies Inc. benefit from sector rotation2025 Pullback Review & Smart Investment Allocation Insights - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Gains Recap: Can Taysha Gene Therapies Inc. deliver alpha2025 Retail Activity & Stock Portfolio Risk Management - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

How liquid is Taysha Gene Therapies Inc. stockWeekly Earnings Recap & Weekly Top Stock Performers List - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

What’s next for Taysha Gene Therapies Inc. stock priceJuly 2025 WrapUp & Expert Curated Trade Setup Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What institutional flow reveals about Taysha Gene Therapies Inc.Portfolio Return Report & Weekly High Momentum Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 02:33:41 - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Applying big data sentiment scoring on Taysha Gene Therapies Inc.2025 Breakouts & Breakdowns & Real-Time Volume Triggers - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using data filters to optimize entry into Taysha Gene Therapies Inc.Dollar Strength & Reliable Breakout Forecasts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Taysha Gene Therapies Inc.’s volatility index tracking explainedJuly 2025 Snapshot & Fast Moving Market Watchlists - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Taysha Gene Therapies Inc. a candidate for recovery playMarket Trend Review & Stepwise Trade Signal Implementation - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Taysha Gene Therapies Inc. stock go up soonJuly 2025 WrapUp & Advanced Swing Trade Entry Plans - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Taysha Gene Therapies Inc. stock prediction for this weekJuly 2025 Macro Moves & AI Enhanced Trading Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Using portfolio simulators with Taysha Gene Therapies Inc. includedMarket Rally & Low Drawdown Investment Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Taysha Gene Therapies Inc. stock entering bullish territoryJuly 2025 Summary & Scalable Portfolio Growth Methods - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can Taysha Gene Therapies Inc. outperform under higher oil pricesJuly 2025 Review & Growth Focused Stock Reports - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

How to build a custom watchlist for Taysha Gene Therapies Inc.Profit Target & Accurate Intraday Trading Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How high can Taysha Gene Therapies Inc. stock go2025 Key Lessons & AI Based Buy/Sell Signal Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Taysha Gene Therapies Inc. stock reversal real or fakeJuly 2025 Reactions & Short-Term High Return Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Taysha Gene Therapies Inc. stock volume spike explainedPortfolio Value Summary & Expert Approved Momentum Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How does Taysha Gene Therapies Inc. perform in inflationary periodsJuly 2025 Sector Moves & Intraday High Probability Setup Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Taysha Gene Therapies Inc. forming a reversal patternEarnings Recap Summary & Daily Stock Trend Watchlist - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What earnings revisions data tells us about Taysha Gene Therapies Inc.Portfolio Gains Report & Daily Risk Controlled Trade Plans - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Can volume confirm reversal in CleanSpark Inc.July 2025 Price Swings & Accurate Trade Setup Notifications - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

RSI Suggests Rebound May Be Near in Taysha Gene Therapies Inc.July 2025 Snapshot & Momentum Based Trading Signals - beatles.ru

Sep 01, 2025
pulisher
Sep 01, 2025

Multi asset correlation models including Taysha Gene Therapies Inc.Market Movers & High Accuracy Buy Signal Tips - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Taysha Gene Therapies’ Earnings Call: Progress Amid Challenges - TipRanks

Aug 31, 2025
pulisher
Aug 31, 2025

Taysha Gene Therapies Inc. stock daily chart insightsJuly 2025 Retail & Reliable Price Breakout Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Real time breakdown of Taysha Gene Therapies Inc. stock performanceJuly 2025 Opening Moves & Weekly Momentum Stock Picks - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Real time alert setup for Taysha Gene Therapies Inc. performance2025 Big Picture & Accurate Entry and Exit Point Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Are Bears Losing Grip on Taysha Gene Therapies Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스

Aug 31, 2025
pulisher
Aug 30, 2025

Real time social sentiment graph for Taysha Gene Therapies Inc.July 2025 Market Mood & High Accuracy Trade Signal Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Heatmap analysis for Taysha Gene Therapies Inc. and competitorsQuarterly Investment Review & Precise Buy Zone Identification - Newser

Aug 30, 2025

Finanzdaten der Taysha Gene Therapies Inc-Aktie (TSHA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Taysha Gene Therapies Inc-Aktie (TSHA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Alam Kamran
CHIEF FINANCIAL OFFICER
Aug 21 '25
Sale
2.85
54,491
155,299
1,187,603
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):